A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects

Trial Profile

A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Aug 2015

At a glance

  • Drugs Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals
  • Indications HIV-1 infections
  • Focus Adverse reactions
  • Acronyms HIV
  • Sponsors Gilead Sciences
  • Most Recent Events

    • 30 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 28 Feb 2014 Planned End Date changed from 22 Jun 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov record.
    • 06 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top